Advantage of antithymocyte globulin induction in sensitized kidney recipients: A randomized prospective study comparing induction with and without antithymocyte globulin

Nephrology Dialysis Transplantation

Volumn 13, Issue 3, 1998, Pages 711-715

  Thibaudin, Damien ^a   Alamartine, Eric ^a,b   De Filippis, Jean Pierre ^a   Diab, Nabil ^a   Laurent, Blandine ^a   Berthoux, François ^a  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^b HÔPITAL NORD   (France)

Author keywords

Antithymocyte globulin; Immunosuppression; Induction therapy; Renal transplantation; Triple therapy

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; STEROID; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECIPIENT; THROMBOCYTOPENIA;

ADULT; ANTILYMPHOCYTE SERUM; CYCLOSPORINE; FEMALE; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 0031930886     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.3.711     Document Type: Article

References (28)

1. Sanfilippo F, Vaughn WK, Lefor WN, Spees EK. Multivariate analysis of risk factors affecting renal transplantation. Transplantation 1986; 42: 28-34
2. Opelz G. Kidney transplantation in sensitized patients. Transplant Proc 1987; 19: 3737-3741
3. Turka LA, Goguen JE, Gagne JE, Milford LE. Presensitization and the renal allograft recipient. Transplantation 1989; 47: 234-240:
4. Opelz G. Comparison of immunossuppressive protocols in renal transplantation: a multicenter view. Transplant Proc 1988; 20: 31-36
5. Cecka JM, Gjertson D, Terasaki PI. Do prophylactic antilymphocyte globulins (ALG and OKT3) improve renal transplant survival in recipient and donor high risk groups? Transplant Proc 1993; 25: 548-549
6. Matas AJ, Tellis VA, Quinn TA, Glicklich D, Soberman R, Veith FJ. Individualization of immediate posttransplant immunosuppression. Transplantation 1988; 45: 406-409
7. Michael HJ, Francos GC, Burke JF et al. A comparison of the effects of cyclosporin versus antilymphocyte globulin on delayed graft function in cadaver renal transplant recipients. Transplantation 1989; 48: 805-808
8. Abramowicz D, Norman DJ, Vereerstraeten P et al. OKT3 prophylaxis in renal grafts with prolonged cold ischemia times: association with improvement in long-term survival. Kidney Int 1996; 49: 768-772
9. Grino JM, Alsina J, Sabater R et al. Antilymphoblast globulin, cyclosporin and steroids in cadaveric renal transplantation. Transplantation 1990; 49: 1114-1117
10. Hiesse C, Fries D, Charpentier B et al. Optimal results in cadaver donor renal transplantation using prophylactic ALG, cyclosporin, and prednisone. Transplant Proc 1987; 29: 3670-3671
11. Schleibner S, Hillebrand G, Illner WD, Hohnke C, Steitz HO, Land W. Immunosuppressive quadruple drug induction therapy in sensitized renal allograft recipients. Transplant Proc 1987; 29: 3752-3753
12. Vela C, Cristol JP, Chong G et al. Antilymphocyte globulins versus OKT3 as prophylactic treament in highly sensitized renal transplant recipients. Transplant Int 1994; 7 [Supp 1]: S259-S262
13. Abramowicz D, Goldman M. Efficacy of rejection prophylaxis with OKT3. Transplantation 1997; 62: 700-701
14. Schroeder TJ, First MR, Mansour ME, Alexander JW, Penn I. Prophylactic use of OKT3 in immunologic high-risk cadaver renal recipients. Am J Kidney Dis 1989; 14: 14-18
15. Pomer S, Waldherr R, Mohring K, Kempter F, Wiesel M, Weimer R. Prospective trial of OKT3 for early prophylaxis of rejections in immunologic high risk renal transplant recipients: long-term results. Transplant Proc 1992; 24: 1732-1733
16. Abramowicz D, Goldman M, De Paul L, Vanherweghen JL, Kinnaert P, Vereestraeten P. The long-term effects of prophylactic OKT3 monoclonal antibody in cadaver kidney transplantation - a single-center, prospective, randomized study. Transplantation 1992; 54: 433-437
17. Norman DJ, Kahana L, Stuart FP et al. A randomized clinical trial of induction therapy with OKT3 in kidney transplantation. Transplantation 1993; 55: 44-50
18. Taube D. Immunoadsorpion in the sensitized patients. Kidney Int 1990; 38: 350-358
19. Frey DJ, Matas AJ, Gillingham KJ et al. Sequential therapy. A prospective randomized trial of MALG versus OKT3 for prophylactic immunosuppression in cadaver renal allograft recipients. Transplantation 1992; 54: 50-56
20. Lefrancois N, Brune M, Najem R et al. Immunosuppression in patients with hyperimmunisation or retransplantation. In: Touraine JL et al., eds. Transplantation and Clinical Immunology. Elsevier Science, Amsterdam: 1992; Vol. 26: 259-264
21. Grino JM, Castelao AM, Seron D et al. Prophylactic OKT3, CyA, and steroids versus antilymphoblast globulin, cyclosporin, and steroids in cadaveric kidney transplantation. Transplant Proc 1992; 24: 39-41
22. Keown PA. The highly sensitized patients. Transplant Proc 1987; 19: 174
23. Tiwari J, Terasaki PI, Mickey MR. Factors influencing kidney graft survival in the cyclosporin era: a multivariate analysis. Transplant Proc 1987; 19: 1839-1841
24. Gaber AO, Thistlethwaite JR, Jr, Haag BW et al. Potent immunosuppression overcomes retransplantation, presensitization and historical positive crossmatch as transplant risk factors. Transplant Proc 1987; 19: 1915-1916
25. Shield CF, Cosimi AB, Toikoff-Rubin N, Rubbin RH, Herrin J, Russel PS. Use of antithymocyte globulins for reversal of acute rejection allograft. Transplantation 1979; 28: 461-464
26. Strata RJ, D'Alessandro AM, Armbrust MJ et al. Sequential antilymphocyte globulin/cyclosporin immunosuppression in cadaveric renal transplantation. Transplantation 1989; 47: 96-102
27. Clark KR, Forsythe JLR, Shenton BK, Lennard TWJ, Proud G, Taylor RMR. Administration of ATG according to the absolute T lymphocyte count during therapy for steroid-resistant rejection. Transplant Int 1993; 6: 18-21
28. Donan M, Coppage M, Ruth J, Rish T, Winsett O, Vaidya S. Renal allograft survival in highly sensitized patients treated with cyclosporin. Transplant Proc 1987; 19: 1988